ARCHIVES

Phase II Study Cohort Fails To Overcome Erlotinib Resistance

This article is from The Cancer Letter archive.

Vol. 36 No. 4 | April 26, 2013

Download PDF Visit The Full Archive

Related Articles

In Brief: Weiner Elected President-Elect of AACI

February 15, 2013

Mammography For Women Under 50 Debated; Cut Of 3-4% Offered As Budget Trimmer

July 23, 1976

Charles Moertel, Mayo Clinic Investigator, Advocate Of Rigorous Trials, Dead At 66

July 8, 1994

Gleevec First Pediatric Cancer Approval By FDA In 13 Years

May 30, 2003

NCI To Offer Expanded Access To Oxaliplatin

May 31, 2002

UK Research Groups To Fund Virtual Tumor Bank

April 18, 2003